Dr. Osman Shabir

Feature Writer

B.Sc. Biomedical Science, M.Sc. Translational Neuroscience, Ph.D. Molecular Neuroscience & Neurophysiology

Osman is a Postdoctoral Research Associate at the University of Sheffield studying the impact of cardiovascular disease (atherosclerosis) on neurovascular function in vascular dementia and Alzheimer's disease using pre-clinical models and neuroimaging techniques. He is based in the Department of Infection, Immunity & Cardiovascular Disease in the Faculty of Medicine at Sheffield.

Osman graduated with a B.Sc. with honors in Biomedical Sciences from the University of Sheffield, where he specialized in Neuroscience.

He went on to complete a Master's of Science (M.Sc.) in Translational Neuroscience (in SITraN) specializing in molecular neuroscience of motor-neuron disease (2016).

He further went on to complete a Ph.D. in Neurovascular Neuroscience (2020) studying neurovascular function in preclinical models of atherosclerosis and Alzheimer's disease. His Ph.D. work formed the basis of his current postdoctoral work which is funded by a British Heart Foundation grant.

He currently writes articles on neuroscience topics such as Multiple Sclerosis, Huntington's Disease, Autism, Parkinson's, and Alzheimer's disease, in addition to a wide variety of other biomedical disciplines for News-Medical.

See less

Articles from Osman

Picky Eating and Autism: Tips & Advice

In addition to the classical symptoms of autism, such as behavioural disturbances, delay in learning to speak, inappropriate social interaction, obsession over particular objects or foods, lack of eye contact, and language comprehension issues, there may also be signs of abnormal eating behaviour, which may or may not be attributed to specific eating disorders.

19 Feb 2019

Autism and Sleep Problems

Autism spectrum disorders (ASD) are a group of neurodevelopmental disorders characterised by impaired social interactions and communications in different settings/multiple contexts.

18 Feb 2019

Can CBD Oil Be Used to Treat Epilepsy?

Cannabis is one of the most widely used recreational drugs worldwide. It comes in many variations that have been used both for medicinal purposes e.g. in the treatment or management of various diseases, as well for recreational purposes to achieve a ‘high’.

23 Jan 2019

CBD Oil and Parkinson’s Disease

Cannabis is the most widely used recreational drug worldwide, with many variants that have been used both medicinally in the treatment or management of various diseases, including chronic pain, as well as being used recreationally to achieve a high.

23 Jan 2019

Antibodies and Huntington's: Diagnosis & Treatment

Huntington’s disease is a genetically inherited neurodegenerative disorder caused by an autosomal dominant mutation in the huntingtin gene resulting in a trinucleotide (CAG) repeat expansion with over 40 repeats.

23 Jan 2019

Omega-3 and Alzheimer’s Disease

This article examines whether a diet rich in omega-3 fatty acids could be beneficial in restoring cognitive performance in Alzheimer's disease.

15 Jan 2019

Alzheimer’s Disease and Gingko Biloba

Extensive analyses of the multiple studies performed to analyze the efficacy of EGb761 in the treatment of dementia have shown mixed results.

21 Dec 2018

Alzheimer’s Disease and Calcium Supplements

This article explains a recent study suggesting that calcium supplementation may increase the risk of Alzheimer's disease.

21 Dec 2018

Alzheimer's Disease and the Microbiome

There are more than ten times as many bacteria and other microorganisms in our bodies as there are human cells. Bacteria, viruses, fungi and other microorganisms reside within the digestive tract, primarily within the intestines, and play a fundamental role in digestive and immune health.

12 Nov 2018

Stress and Alzheimer's Disease

Stress is often a factor that contributes to or worsens many conditions ranging from psoriasis to irritable bowel syndrome, perhaps because it results in compromised immunity. Recent evidence has shown that stress may be involved in accelerating the onset of Alzheimer’s disease as well as worsening the disease course.

11 Nov 2018